Filing Flows › Pulse Biosciences (PLSE) › R&D spending
Pulse Biosciences (PLSE) R&D spending by quarter
Pulse Biosciences' R&D spending was $16.8M in Q3 2026 (third quarter 2026), -0.8% from Q2 2026. Over the last 5 quarters it ranged from $10.9M (Q4 2025) to $17.0M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.8M | -0.8% | +48% |
| Q2 2026 | $17.0M | +35% | — |
| Q1 2026 | $12.6M | +15% | — |
| Q4 2025 | $10.9M | -4% | — |
| Q3 2025 | $11.4M | — | — |
Q3 2026 at a glance
Pulse Biosciences, Q3 2026: revenue $395K (+359% year over year), net loss $23.1M, operating cash flow −$15.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Pulse Biosciences' R&D spending?
Pulse Biosciences' R&D spending was $16.8M in Q3 2026 (third quarter 2026), -0.8% from Q2 2026.
How has Pulse Biosciences' R&D spending changed?
Over the last 5 quarters it ranged from $10.9M (Q4 2025) to $17.0M (Q2 2026).